Management of Loose, Greasy Stools from Cow's Milk in Cystic Fibrosis
Measure fecal elastase immediately to assess pancreatic function, optimize pancreatic enzyme replacement therapy if insufficient, and if symptoms persist despite adequate enzyme dosing, eliminate cow's milk from the diet and substitute with a cow's milk protein-free formula.
Initial Assessment and Pancreatic Function
The first critical step is determining whether this represents pancreatic insufficiency or a separate cow's milk-related enteropathy. Fecal elastase should be measured at initial assessment as recommended for all CF patients 1. This is particularly important because:
- Most CF patients are pancreatic insufficient, which causes steatorrhea (greasy stools)
- Pancreatic enzyme replacement therapy should be introduced early and monitored regularly when indicated 1
- The presence of pancreatic insufficiency strongly supports CF diagnosis and requires immediate treatment
Optimize Pancreatic Enzyme Replacement First
If fecal elastase indicates pancreatic insufficiency:
- Ensure adequate pancreatic enzyme dosing - this is the most common cause of persistent steatorrhea in CF
- Adjust enzyme dose based on fat content of meals
- Verify proper timing and administration technique
- Monitor for improvement in stool consistency and weight gain
Consider Cow's Milk Sensitive Enteropathy
If symptoms persist despite adequate pancreatic enzyme replacement, cow's milk sensitive enteropathy must be considered. This is a well-documented phenomenon in CF patients:
Key evidence supporting this diagnosis:
- In one study, 8% of CF children under 3 years had cow's milk sensitive enteropathy causing failure to thrive despite adequate treatment 2
- 90% of CF patients with persistent diarrhea and failure to thrive improved when implicated foods were eliminated 3
- Seven of eight CF children with documented enteropathy on biopsy responded to a cow's milk-free diet with cessation of diarrhea and increased weight gain 2
Diagnostic Approach for Milk Enteropathy
Clinical indicators suggesting cow's milk enteropathy:
- Persistent loose, greasy stools despite optimized pancreatic enzymes
- Failure to thrive or poor weight gain
- Age under 3 years (most susceptible period)
- Symptoms that don't correlate with enzyme dosing
Immunological testing may be helpful:
- Specific IgG, IgA, and IgM antibodies to casein, beta-lactoglobulin, and ovalbumin were significantly elevated in CF patients with food allergy 3
- These are more useful than skin tests or IgE levels for this diagnosis
Treatment Algorithm
Step 1: Eliminate Cow's Milk
- Remove all cow's milk and cow's milk-based products from diet
- Use nutritionally complete, cow's milk protein-free formulas 4
- Continue pancreatic enzyme replacement therapy
Step 2: Monitor Response
- Symptoms should improve within days to weeks if milk enteropathy is present
- Monitor weight gain and stool consistency
- 78% of CF patients had positive oral provocation tests confirming the diagnosis 3
Step 3: Duration and Reintroduction
- This is a temporary disorder - the enteropathy resolves between 15 months to 3 years of age 2
- All children in the study tolerated normal diet and continued to thrive after this period
- Reintroduction of cow's milk is nearly always possible between 1 and 2 years of age 4
- Challenge with cow's milk when child is gaining weight, thriving, and symptom-free
Critical Pitfalls to Avoid
- Don't assume all steatorrhea is from pancreatic insufficiency - cow's milk enteropathy is an important but often overlooked cause in CF patients under 3 years
- Don't use inadequate substitutes - only nutritionally complete formulas free of cow's milk protein are recommended 4
- Don't continue milk elimination indefinitely - this is a temporary disorder requiring periodic challenge to determine when normal diet can resume
- Don't forget to maintain pancreatic enzymes - even with milk elimination, pancreatic insufficient patients still require enzyme replacement
Small Intestinal Biopsy Consideration
Small intestinal biopsy is an important investigation in younger CF children who fail to thrive and have diarrhea despite adequate treatment 2. Biopsy findings show mild-to-moderate partial villous atrophy with thin, often patchy mucosa 4. However, a therapeutic trial of milk elimination is reasonable before proceeding to biopsy, given the high response rate.